Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Psoriasis, Date of authorisation: 17/09/2018, Revision: 1, Status: Authorised

2019 Case Medical Research  
Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact
doi:10.31525/cmr-1059481 fatcat:tnv4nqonanhn7e3kcbx7slp3bi